AtraZeneca's Ultomiris approved in EU for adults with neuromyelitis optica spectrum disorder Ruchika Sharma12 May 2023 1:30 PM ISTNeuromyelitis optica spectrum disorder is a rare and debilitating autoimmune disease that affects the central nervous system including the spine and...
AstraZeneca Farxiga approved in US to reduce risk of cardiovascular death, hospitalisation for heart failure to broader range of patients Ruchika Sharma10 May 2023 12:30 PM ISTCambridge: AstraZeneca has announced that Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death,...
AstraZeneca Koselugo gets Chinese nod for paediatric patients with neurofibromatosis type 1, plexiform neurofibromas Ruchika Sharma9 May 2023 12:30 PM ISTIn addition to China, Koselugo is also approved in the US, EU, Japan and several other countries for the treatment of paediatric patients with NF1 and...
AstraZeneca India to launch centres of excellence for severe asthma in Delhi, Ahmedabad, Kochi and Goa MD Bureau3 May 2023 1:30 PM ISTThe Centers of Excellence for severe asthma, as per the guidelines established by the Global Initiative for Asthma, would concentrate on specialty and...
AstraZeneca beat expectations for first-quarter profit, revenue Ruchika Sharma30 April 2023 12:15 PM ISTLondon: AstraZeneca on Thursday beat expectations for its first-quarter profit and revenue, helped by sales of its roster of drugs in emerging...
AstraZeneca, Sanofi, Sobi simplify contractual agreements for Nirsevimab Ruchika Sharma12 April 2023 3:44 PM ISTBeyfortus (nirsevimab), an investigational long-acting antibody designed to protect all infants against RSV infections from birth through their first...
AstraZeneca announces positive results from ovarian cancer combo therapy trial Ruchika Sharma7 April 2023 11:30 AM ISTThe safety and tolerability of these combinations are broadly consistent with that observed in prior clinical trials and the known profiles of the...
AstraZeneca Ultomiris recommended for marketing approval in EU for neuromyelitis optica spectrum disorder Ruchika Sharma4 April 2023 4:00 PM ISTNMOSD is a rare and debilitating autoimmune disease that affects the central nervous system, including the spine and optic nerves.
AstraZeneca completes global license agreement with KYM Biosciences for CMG901 Ruchika Sharma1 April 2023 10:00 AM ISTUK: AstraZeneca has completed an exclusive global license agreement with KYM Biosciences Inc. for CMG901, a potential first-in-class antibody drug...
AstraZeneca Calquence gets conditional nod in China for adults with previously treated mantle cell lymphoma Ruchika Sharma26 March 2023 10:00 AM ISTMantle cell lymphoma is a rare B-cell malignancy subtype and is typically clinically aggressive with a poor prognosis.
AstraZeneca concludes acquisition of CinCor Pharma Ruchika Sharma26 Feb 2023 2:30 PM ISTUK: AstraZeneca has announced the successful completion of the acquisition of CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical...
AstraZeneca enters license agreement with KYM Biosciences for CMG901 Ruchika Sharma26 Feb 2023 10:00 AM ISTUK: AstraZeneca and KYM Biosciences Inc. have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody...
